The national funding bodies from Austria and Israel have allocated funding for organisations collaborating on international R&D projects.
The partnership will support research and innovation projects within all thematic fields, however the participating countries particularly welcome project applications in the fields of health and bioconvergence, with a broad focus on e.g. of immunology, infectious diseases, design and development of vaccines, preventive measures, fast and reliable diagnostics, novel or repurposed therapeutics or prophylactics, personal protective equipment.
You can submit your Eureka R&D project application for this call for projects between 1 JUNE 2023 and 19 FEB 2024. Your project consortium must include organisations based in Austria and Israel. In addition to those partners, partners from other Eureka countries or countries outside of Eureka can also participate, provided their public funding or self-funding is secured within the call for projects deadlines.
If required by national funding body – which is the case both in Austria and Israel, project participants must also submit a national funding application, considering all relevant national procedures, deadlines and submission rules (see section “Funding conditions and rules per national funding body” for detailed information).
